WebDisclosure WebDisclosure
Basculer en Français
9551 Companies
188477 Keywords
120311 Articles
100641 Press releases
Headlines Articles Press releases GEN İlaç Ve Sağlık Ürünleri A.Ş. Remove
  1. Home
  2. Companies
  3. GEN İlaç Ve Sağlık Ürünleri A.Ş.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/25/2024 at 15:05, 1 year 2 months ago

    GEN Reports Positive Phase 2 Trial Results for GN-037 Topical Cream

    Clinical Efficacy Phase 2 Trial Results GN-037 Topical Cream Plaque Psoriasis Treatment GEN Pharmaceuticals
  • BRIEF

    published on 09/25/2024 at 15:05, 1 year 2 months ago

    GEN annonce des résultats positifs de l'essai de phase 2 pour la crème topique GN-037

    Efficacité Clinique Résultats De L'essai De Phase 2 Crème Topique GN-037 Traitement Du Psoriasis En Plaques GEN Pharmaceutique
  • PRESS RELEASE

    published on 09/25/2024 at 15:00, 1 year 2 months ago

    GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis

    GEN Pharmaceuticals announces positive Phase 2 trial results for GN-037 topical cream in treating plaque psoriasis, presented at EADV Congress 2024
    Phase 2 Trial GN-037 Topical Cream GEN Pharmaceuticals Plaque Psoriasis EADV Congress
    Logo of GEN İlaç Ve Sağlık Ürünleri A.Ş.
Accesswire
  • Published on 12/18/2025 at 18:00, 2 hours 24 minutes ago

    PPX Mining Announces 2025 AGM Results

  • Published on 12/18/2025 at 15:00, 5 hours 24 minutes ago

    Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia

  • Published on 12/18/2025 at 14:31, 5 hours 53 minutes ago

    Worksport Reports Highest Monthly Revenue in Company History

  • Published on 12/18/2025 at 14:00, 6 hours 24 minutes ago

    Route1 Announces Provisional Patent Application

  • Published on 12/18/2025 at 14:00, 6 hours 24 minutes ago

    LQR House Announces $6.52 Million Registered Direct Offering

View all ACCESSWIRE
EQS Group
  • Published on 12/18/2025 at 20:09, 14 minutes ago

    EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond

  • Published on 12/18/2025 at 19:30, 54 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT

  • Published on 12/18/2025 at 19:30, 54 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST

  • Published on 12/18/2025 at 18:48, 1 hour 36 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 12/18/2025 at 18:45, 1 hour 38 minutes ago

    PATRIMOINE ET COMMERCE: PROJET D’AUGMENTATIONS DE CAPITAL DE PATRIMOINE & COMMERCE D’UN MONTANT DE 30 MILLIONS D’EUROS

View all EQS
Les Echos
  • Published on 12/18/2025 at 18:30, 1 hour 54 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

  • Published on 12/18/2025 at 18:30, 1 hour 54 minutes ago

    Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde

  • Published on 12/18/2025 at 17:45, 2 hours 39 minutes ago

    Cie du Bois Sauvage: Vernietiging eigen aandelen

  • Published on 12/18/2025 at 17:45, 2 hours 39 minutes ago

    Damartex réaffirme son éligibilité au PEA-PME

  • Published on 12/18/2025 at 17:45, 2 hours 39 minutes ago

    Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy